Luo Y - Search Results

1

Ginsenoside Ro prevents endothelial injury via promoting Epac1/AMPK- mediated mitochondria protection in early diabetic retinopathy.

Liu J, Zhang Y, Xu X, Dong X, Pan Y, Sun X, Luo Y. Liu J, et al. Among authors: luo y. Pharmacol Res. 2025 Jan;211:107562. doi: 10.1016/j.phrs.2024.107562. Epub 2024 Dec 26. Pharmacol Res. 2025. PMID: 39732351 Free article.

2

Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway.

Luo Y, Lu S, Dong X, Xu L, Sun G, Sun X. Luo Y, et al. Apoptosis. 2017 Aug;22(8):1013-1024. doi: 10.1007/s10495-017-1381-3. Apoptosis. 2017. PMID: 28612103

3

Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.

Qin M, Luo Y, Lu S, Sun J, Yang K, Sun G, Sun X. Qin M, et al. Among authors: luo y. Front Pharmacol. 2017 Dec 22;8:953. doi: 10.3389/fphar.2017.00953. eCollection 2017. Front Pharmacol. 2017. PMID: 29311947 Free PMC article.

4

Ginsenoside Rg1 prevents early diabetic retinopathy via reducing retinal ganglion cell layer and inner nuclear layer cell apoptosis in db/db mice.

Gao Y, Ji Y, Luo Y, Sun J, Sun G, Sun X. Gao Y, et al. Among authors: luo y. Ann Transl Med. 2020 Mar;8(5):232. doi: 10.21037/atm.2019.12.155. Ann Transl Med. 2020. PMID: 32309379 Free PMC article.

5

Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice.

Luo Y, Dong X, Lu S, Gao Y, Sun G, Sun X. Luo Y, et al. Eur J Pharmacol. 2021 Mar 15;895:173893. doi: 10.1016/j.ejphar.2021.173893. Epub 2021 Jan 22. Eur J Pharmacol. 2021. PMID: 33493483

6

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.

Pan Y, Liu J, Ren J, Luo Y, Sun X. Pan Y, et al. Among authors: luo y. Front Pharmacol. 2022 Jul 14;13:929152. doi: 10.3389/fphar.2022.929152. eCollection 2022. Front Pharmacol. 2022. PMID: 35910387 Free PMC article. Review.

7

Diabetic retinopathy: Involved cells, biomarkers, and treatments.

Ren J, Zhang S, Pan Y, Jin M, Li J, Luo Y, Sun X, Li G. Ren J, et al. Among authors: luo y. Front Pharmacol. 2022 Aug 9;13:953691. doi: 10.3389/fphar.2022.953691. eCollection 2022. Front Pharmacol. 2022. PMID: 36016568 Free PMC article. Review.

8

Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA.

Dong X, Lu S, Tian Y, Ma H, Wang Y, Zhang X, Sun G, Luo Y, Sun X. Dong X, et al. Among authors: luo y. J Adv Res. 2024 Jan;55:131-144. doi: 10.1016/j.jare.2023.02.007. Epub 2023 Feb 16. J Adv Res. 2024. PMID: 36801384 Free PMC article.

9

Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review.

Geng Y, Wang Z, Xu X, Sun X, Dong X, Luo Y, Sun X. Geng Y, et al. Among authors: luo y. Transl Res. 2024 Jan;263:73-92. doi: 10.1016/j.trsl.2023.08.001. Epub 2023 Aug 9. Transl Res. 2024. PMID: 37567440 Review.

10

Naoxinqing tablet protects against cerebral ischemic/reperfusion injury by regulating ampkα/NAMPT/SIRT1/PGC-1α pathway.

Sun X, Pan Y, Luo Y, Guo H, Zhang Z, Wang D, Li C, Sun X. Sun X, et al. Among authors: luo y. J Ethnopharmacol. 2024 Mar 25;322:117672. doi: 10.1016/j.jep.2023.117672. Epub 2023 Dec 28. J Ethnopharmacol. 2024. PMID: 38159826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,830 results

Search Page

Filters